NEW YORK, April 13, 2016 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Implanet S.A. (Euronext Paris IMPL; OTCQX: IMPZY), a French medical technology company specializing in vertebral and knee-surgery implants, has qualified to have its American Depositary Receipts (ADRs) trade on the OTCQX® Best Market. Implanet upgraded to OTCQX from the Pink® market.
Implanet begins trading today on OTCQX under its existing stock symbol "IMPZY," where each ADR represents two ordinary shares. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"We are thrilled to welcome Implanet to our family of established, investor-focused U.S. and global companies," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "Trading on OTCQX will allow Implanet to expand its shareholder base and visibility in the U.S. market without incurring the high cost and duplicative regulatory requirements of a U.S. stock exchange listing. We look forward to being part of Implanet's continued growth and success."
David Dieumegard, CFO of Implanet, commented, "Given our increased presence in the U.S. following the recent FDA clearance of our latest device to address the degenerative spine market, JAZZ Lock®, we are very pleased that our ADRs are now trading on the OTCQX market. OTCQX provides Implanet the opportunity to create a better informed and more efficient marketplace for U.S.-based investors. Joining OTCQX will complement our presence on EURONEXT, while facilitating and enhancing global trading in Implanet's shares."
BNY Mellon serves as Implanet's Principal American Liaison ("PAL") on OTCQX, responsible for providing professional guidance on OTCQX requirements.
Implanet is a medical technology company based in France. The company is engaged in the manufacturing, marketing and commercial development of implants and medical devices used in orthopedic surgery. The company's product range covers knee surgery with a full range of total knee prosthesis and sport medicine implants. The company's flagship product, the JAZZ technology platform, provides immobilization and fusion of spinal segments in the reduction of large deformities as well as the treatment of aging population. JAZZ is an adjunct to fusion implant of cervical, thoracic and lumbar spine.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-implanet-sa-to-otcqx-300250367.html
SOURCE OTC Markets Group Inc.